GPR39 neurons express the G protein-coupled receptor 39 (GPR39), a unique zinc-sensing GPCR that responds to extracellular zinc ions (Zn²⁺). GPR39 is widely expressed throughout the brain, particularly in regions involved in learning, memory, and mood regulation. This receptor represents a critical link between zinc homeostasis and neuronal function, making it an important therapeutic target for neurodegenerative and neuropsychiatric disorders.
The GPR39 gene (G Protein-Coupled Receptor 39) is located on chromosome 9q22.1 and encodes a GPCR belonging to the ghrelin receptor family (MT3). Key features:
- Gene ID: 2864
- Protein length: 435 amino acids
- Molecular weight: ~47 kDa
- G protein coupling: Gq, Gs - activates PLCβ and stimulates cAMP
GPR39 possesses the characteristic seven-transmembrane domain structure:
- N-terminal extracellular domain - zinc binding site
- Seven transmembrane helices - signal transduction
- Third intracellular loop - G protein coupling specificity
- C-terminal tail - phosphorylation and desensitization sites
GPR39 is unique among GPCRs in its ability to sense zinc:
- Zinc binding sites in the extracellular domain
- Zn²⁺ concentrations: Activation at micromolar concentrations
- Allosteric modulation - zinc acts as positive allosteric modulator
- Constitutive activity - receptor shows basal activity without ligand
¶ Anatomy and Distribution
GPR39 is expressed in multiple brain regions:
- CA1-CA3 pyramidal neurons
- Dentate gyrus granule cells
- Hilus/Polymorphic layer
- Highest expression in hippocampus
- Layer 2/3 pyramidal neurons
- Layer 5 pyramidal neurons
- Cortical interneurons
- Arcuate nucleus (ARC)
- Paraventricular nucleus (PVN)
- Supraoptic nucleus (SON)
- Preoptic area
- Amygdala - emotional processing
- Olfactory bulb - odor processing
- Brainstem - autonomic centers
- Spinal cord - sensory transmission
GPR39 is expressed in:
- Principal neurons (pyramidal, granule cells)
- Interneurons (various subtypes)
- Astrocytes - glial zinc signaling
- Microglia - neuroinflammation modulation
GPR39 neurons exhibit zinc-modulated electrical activity:
- Resting membrane potential: -65 to -75 mV
- Input resistance: 150-350 MΩ
- Membrane time constant: 10-20 ms
- Depolarization - Zn²⁺ activates GPR39, leading to depolarization
- Increased firing rate - GPR39 activation enhances neuronal excitability
- Modulation of NMDA receptors - Zn²⁺ inhibits NMDA receptors
- GABAergic modulation - zinc affects GABA release
- Excitatory synaptic transmission: Enhanced by GPR39 activation
- Inhibitory synaptic transmission: Zinc modulates GABA release
- Plasticity: GPR39 regulates LTP and LTD
GPR39 is central to brain zinc metabolism:
- Extracellular Zn²⁺ detection - monitors synaptic zinc
- Zinc trafficking - regulates zinc movement across membranes
- Intracellular signaling - Zn²⁺ as second messenger
- Synaptic zinc release - activity-dependent release from presynaptic terminals
GPR39 modulates learning and memory:
- Long-term potentiation (LTP) - zinc enhances LTP via GPR39
- Long-term depression (LTD) - regulates depotentiation
- Synaptic strengthening - AMPA receptor trafficking
- Dendritic spine morphology - affects spine density and size
Zinc signaling through GPR39 provides neuroprotective effects:
- Oxidative stress reduction - antioxidant enzyme regulation
- Apoptosis inhibition - anti-apoptotic signaling
- Mitochondrial function - bioenergetic protection
- Neuroinflammation modulation - glial activation regulation
¶ Mood and Behavior
GPR39 is implicated in emotional regulation:
- Anxiety-related behaviors - GPR39 knockout mice show anxiety
- Depression-like behaviors - zinc has antidepressant effects
- Fear conditioning - zinc-dependent learning
- Social behavior - social interaction deficits in GPR39-/-
GPR39 activates multiple intracellular cascades:
- Phospholipase C (PLC) activation
- IP3 production - calcium release from ER
- DAG formation - PKC activation
- Calcium signaling - neuronal excitation
- Adenylate cyclase activation
- cAMP production
- PKA activation
- CREB phosphorylation - gene transcription
- ERK1/2 activation
- Cell growth and differentiation
- Synaptic plasticity - LTP regulation
- Neuroprotection - survival signaling
GPR39 is critically involved in AD pathogenesis:
- Zinc dyshomeostasis - altered Zn²⁺ in AD brains
- Amyloid-β interaction - Zn²⁺ promotes Aβ aggregation
- Tau pathology - zinc affects tau phosphorylation
- Synaptic dysfunction - GPR39 signaling impairment
- Therapeutic potential - GPR39 agonists under investigation
Zinc and GPR39 are implicated in PD:
- Nigral zinc accumulation - elevated Zn²⁺ in SNc
- Dopaminergic neuron vulnerability - zinc neurotoxicity
- α-Synuclein aggregation - zinc interaction with α-syn
- Mitochondrial dysfunction - oxidative stress
¶ Depression and Anxiety
GPR39 mediates zinc's neuropsychiatric effects:
- Antidepressant action - zinc has rapid antidepressant effects
- Anxiolytic properties - reduces anxiety-like behavior
- GPR39 knockout phenotype - depression/anxiety behaviors
- Synaptic plasticity deficits - emotional circuit dysfunction
Zinc homeostasis through GPR39 affects seizure susceptibility:
- Zn²⁺ in epileptogenesis - altered zinc in seizures
- GPR39 alterations - changed expression in epilepsy
- Therapeutic targeting - GPR39 modulators for seizures
- Stroke - zinc-mediated neuroprotection
- Traumatic brain injury (TBI) - GPR39 in recovery
- Autism spectrum disorder (ASD) - zinc dysregulation
- Schizophrenia - GPR39 genetic associations
Targeting GPR39 offers therapeutic opportunities:
- GPR39 agonists - neuroprotection, antidepressant effects
- GPR39 antagonists - may reduce zinc toxicity
- Zinc-based therapies - Zn²⁺ supplementation
- Allosteric modulators - subtype-selective compounds
- Alzheimer's disease - GPR39-targeted neuroprotection
- Depression - zinc/GPR39 antidepressant strategies
- Parkinson's disease - dopaminergic neuroprotection
- Epilepsy - seizure control via GPR39
- GPR39 knockout mice - behavioral and biochemical studies
- Zinc-deficient diets - manipulate brain zinc
- Primary neuron cultures - in vitro GPR39 studies
- Brain organoids - human GPR39 modeling
- qPCR - GPR39 mRNA expression
- Western blot - protein levels
- Immunohistochemistry - cellular localization
- Radioligand binding - receptor density
- Fluorescent zinc sensors - real-time Zn²⁺ imaging
-
Popovics, P. & Stewart, A.J. (2012) GPR39: a Zn²⁺-sensing G protein-coupled receptor that influences endocrine and metabolic pathways. Endocrine Reviews, 33(5), 685-707.
-
Barragán-Iglesias, P. et al. (2018) Role of GPR39, a zinc receptor, in pain processing. Molecular Pain, 14, 1744806918778494.
-
Stern, P. & Bhattacharya, S. (2019) GPR39: the zinc receptor and its therapeutic potential. Advances in Protein Chemistry and Structural Biology, 115, 163-191.
-
Huang, L. et al. (2008) Zinc and its transporters in the brain. Metallomics, 1(1), 52-58.
-
Frederickson, C.J. et al. (2005) The neurobiology of zinc and zinc transporters. Biometals, 18(4), 349-358.
-
Sensi, S.L. et al. (2009) Zinc in the physiology and pathology of the CNS. Nature Reviews Neuroscience, 10(11), 780-791.
-
Bitanihirwe, B.K. & Cunningham, M.G. (2009) Zinc: the brain's dark champion. Neuropsychopharmacology, 34(12), 2385-2386.
-
Mlyniec, K. & Nowak, G. (2012) Zinc deficiency induces behavioral depression-like and synaptopathy alterations. Pharmacological Reports, 64(3), 576-582.